Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
27.01
+0.91 (3.49%)
Apr 29, 2026, 3:04 PM CST
SHE:301206 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 324.99 | 160.29 | 108.81 | 489.04 | 515.72 |
Short-Term Investments | - | 2,670 | - | - | - |
Trading Asset Securities | 123.37 | - | - | - | 0.33 |
Cash & Short-Term Investments | 448.35 | 2,830 | 108.81 | 489.04 | 516.05 |
Cash Growth | -84.16% | 2501.17% | -77.75% | -5.23% | 129.38% |
Accounts Receivable | 85.5 | 122.37 | 80.93 | 51.11 | 141.36 |
Other Receivables | 5.07 | 277.58 | 6.55 | 12.82 | 21.11 |
Receivables | 90.57 | 399.95 | 87.48 | 63.94 | 162.47 |
Inventory | 174.58 | 142.71 | 104.33 | 96.77 | 112.16 |
Other Current Assets | 1,450 | 15.05 | 21.2 | 19.62 | 14.95 |
Total Current Assets | 2,164 | 3,388 | 321.81 | 669.37 | 805.62 |
Property, Plant & Equipment | 1,147 | 1,047 | 987.27 | 952.98 | 770.61 |
Long-Term Investments | 42.19 | 53.18 | 56.01 | 60.16 | - |
Other Intangible Assets | 74.67 | 46.43 | 47.58 | 48.73 | 49.14 |
Long-Term Deferred Tax Assets | - | - | - | - | 2.52 |
Other Long-Term Assets | 990.67 | 270.33 | 3,395 | 3,139 | 6.27 |
Total Assets | 4,419 | 4,805 | 4,808 | 4,870 | 1,634 |
Accounts Payable | 95.85 | 175.7 | 208.57 | 184.31 | 542.47 |
Accrued Expenses | 7.59 | 8.65 | 7.69 | 9.3 | 6.71 |
Current Income Taxes Payable | 1.17 | 0 | - | - | 3.4 |
Current Unearned Revenue | 11.3 | 4.82 | 5.18 | 4.22 | 11.43 |
Other Current Liabilities | 2.07 | 54.51 | 2.75 | 9.68 | 0.8 |
Total Current Liabilities | 117.99 | 243.67 | 224.2 | 207.51 | 564.81 |
Long-Term Unearned Revenue | 2.44 | 3.51 | 4.59 | 0.86 | 0.99 |
Long-Term Deferred Tax Liabilities | 59.29 | 66.87 | 43.61 | 40.78 | 23.03 |
Total Liabilities | 179.71 | 314.04 | 272.4 | 249.14 | 588.83 |
Common Stock | 202.33 | 202.33 | 202.33 | 202.33 | 101.16 |
Additional Paid-In Capital | 3,517 | 3,518 | 3,518 | 3,518 | 72.13 |
Retained Earnings | 579.83 | 788.87 | 815.19 | 900.84 | 872.03 |
Treasury Stock | -60.69 | -17.6 | - | - | - |
Comprehensive Income & Other | 0.16 | - | - | - | - |
Shareholders' Equity | 4,239 | 4,491 | 4,535 | 4,621 | 1,045 |
Total Liabilities & Equity | 4,419 | 4,805 | 4,808 | 4,870 | 1,634 |
Net Cash (Debt) | 448.35 | 2,830 | 108.81 | 489.04 | 516.05 |
Net Cash Growth | -84.16% | 2501.17% | -77.75% | -5.23% | 129.38% |
Net Cash Per Share | 2.26 | 14.02 | 0.54 | 2.45 | 3.40 |
Filing Date Shares Outstanding | 200.18 | 200.45 | 202.33 | 202.33 | 202.33 |
Total Common Shares Outstanding | 200.18 | 200.45 | 202.33 | 202.33 | 151.74 |
Working Capital | 2,046 | 3,144 | 97.62 | 461.86 | 240.81 |
Book Value Per Share | 21.18 | 22.41 | 22.41 | 22.84 | 6.89 |
Tangible Book Value | 4,164 | 4,445 | 4,488 | 4,572 | 996.19 |
Tangible Book Value Per Share | 20.80 | 22.17 | 22.18 | 22.60 | 6.56 |
Buildings | - | 215.87 | 172.81 | 138.83 | 64.98 |
Machinery | - | 994.69 | 864.93 | 786.97 | 410.28 |
Construction In Progress | - | 48.65 | 103.69 | 125.13 | 357.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.